drugset / Trial / NCT01547689

Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease

NCT01547689 ↗

NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study is to evaluate the safety and the tolerability of UC-MSC (Human Umbilical Cord-Derived Mesenchymal Stem Cell) .This study is also to investigate the efficacy of this treatment in patients with Alzheimer's disease (AD).

Timeline

Start
2012-03
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Umbilical Cord Derived MSC Cell therapy 500000 cells/kg Intravenous
Subject Human Umbilical Cord Derived MSC Cell therapy 2e+07 cells Intravenous

Indications